Johnson & Johnson JNJ Stock
Johnson & Johnson Price Chart
Johnson & Johnson JNJ Financial and Trading Overview
| Johnson & Johnson stock price | 257.77 USD |
| Previous Close | 259.1 USD |
| Open | 260.19 USD |
| Bid | 256.11 USD x 10000 |
| Ask | 256.18 USD x 20000 |
| Day's Range | 255.52 - 261.3 USD |
| 52 Week Range | 154.8 - 269.43 USD |
| Volume | 5.22M USD |
| Avg. Volume | 8.21M USD |
| Market Cap | 618.61B USD |
| Beta (5Y Monthly) | 0.235 |
| PE Ratio (TTM) | 30.021029 |
| EPS (TTM) | 8.63 USD |
| Forward Dividend & Yield | 5.36 (2.06%) |
| Ex-Dividend Date | May 26, 2026 |
| 1y Target Est | 258.59 USD |
JNJ Valuation Measures
| Enterprise Value | 651.54B USD |
| Trailing P/E | 30.021029 |
| Forward P/E | 20.164024 |
| PEG Ratio (5 yr expected) | 5.06 |
| Price/Sales (ttm) | 6.419612 |
| Price/Book (mrq) | 7.617608 |
| Enterprise Value/Revenue | 6.761 |
| Enterprise Value/EBITDA | 18.982 |
Trading Information
Johnson & Johnson Stock Price History
| Beta (5Y Monthly) | 0.235 |
| 52-Week Change | 65.13% |
| S&P500 52-Week Change | 20.51% |
| 52 Week High | 269.43 USD |
| 52 Week Low | 154.8 USD |
| 50-Day Moving Average | 235.53 USD |
| 200-Day Moving Average | 220.66 USD |
JNJ Share Statistics
| Avg. Volume (3 month) | 8.21M USD |
| Avg. Daily Volume (10-Days) | 8.71M USD |
| Shares Outstanding | 2.41B |
| Float | 2.4B |
| Short Ratio | 2.96 |
| % Held by Insiders | 0.046% |
| % Held by Institutions | 76.86% |
| Shares Short | 26.58M |
| Short % of Float | 1.23% |
| Short % of Shares Outstanding | 1.09% |
Dividends & Splits
| Trailing Annual Dividend Rate | 5.2 |
| Trailing Annual Dividend Yield | 2.00% |
| 5 Year Average Dividend Yield | 277.00% |
| Payout Ratio | 0.6025 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 28, 2025 |
| Most Recent Quarter (mrq) | March 29, 2026 |
| Next Fiscal Year End | December 28, 2026 |
Profitability
| Profit Margin | 21.83% |
| Operating Margin (ttm) | 27.40% |
| Gross Margin | 68.03% |
| EBITDA Margin | 35.62% |
Management Effectiveness
| Return on Assets (ttm) | 8.42% |
| Return on Equity (ttm) | 26.41% |
Income Statement
| Revenue (ttm) | 96.36B USD |
| Revenue Per Share (ttm) | 40.02 USD |
| Quarterly Revenue Growth (yoy) | 9.90% |
| Gross Profit (ttm) | 65.56B USD |
| EBITDA | 34.33B USD |
| Net Income Avi to Common (ttm) | 21.04B USD |
| Diluted EPS (ttm) | 8.56 |
| Quarterly Earnings Growth (yoy) | -52.40% |
Balance Sheet
| Total Cash (mrq) | 22.05B USD |
| Total Cash Per Share (mrq) | 9.16 USD |
| Total Debt (mrq) | 54.99B USD |
| Total Debt/Equity (mrq) | 67.73 USD |
| Current Ratio (mrq) | 1.025 |
| Book Value Per Share (mrq) | 33.735 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 22.87B USD |
| Levered Free Cash Flow (ttm) | 12.51B USD |
Profile of Johnson & Johnson
| Country | United States |
| State | NJ |
| City | New Brunswick |
| Address | One Johnson & Johnson Plaza |
| ZIP | 08933 |
| Phone | 732 524 0400 |
| Website | https://www.jnj.com |
| Industry | Drug Manufacturers - General |
| Sector(s) | Healthcare |
| Full Time Employees | 138200 |
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Q&A For Johnson & Johnson Stock
What is a current JNJ stock price?
Johnson & Johnson JNJ stock price today per share is 257.77 USD.
How to purchase Johnson & Johnson stock?
You can buy JNJ shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Johnson & Johnson?
The stock symbol or ticker of Johnson & Johnson is JNJ.
Which industry does the Johnson & Johnson company belong to?
The Johnson & Johnson industry is Drug Manufacturers - General.
How many shares does Johnson & Johnson have in circulation?
The max supply of Johnson & Johnson shares is 2.41B.
What is Johnson & Johnson Price to Earnings Ratio (PE Ratio)?
Johnson & Johnson PE Ratio is 29.86906000 now.
What was Johnson & Johnson earnings per share over the trailing 12 months (TTM)?
Johnson & Johnson EPS is 8.63 USD over the trailing 12 months.
Which sector does the Johnson & Johnson company belong to?
The Johnson & Johnson sector is Healthcare.
Johnson & Johnson JNJ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P 500 INDEX
SPX
US
|
7515.34 USD — |
-0.79
|
2.74B USD — | 7506.41 USD — | 7565.37 USD — | — - | 2.74B USD — |
|
S&P 500 (Yahoo.com)
GSPC
US
|
7515.34 USD — |
-0.79
|
2.71B USD — | 7506.41 USD — | 7565.37 USD — | — - | 2.71B USD — |
|
S&P 100
SP100
US
|
3696.58 USD — |
-0.87
|
1.26B USD — | 3693.28 USD — | 3723.37 USD — | — - | 1.26B USD — |
|
Dow Jones Composite Average
DJA
US
|
16937.47 USD — |
-0.06
|
514.36M USD — | 16907.85 USD — | 17029.09 USD — | — - | 514.36M USD — |
|
Dow Jones Industrial Average
DJI
US
|
52498.64 USD — |
-0.26
|
407.34M USD — | 52351.12 USD — | 52846.51 USD — | — - | 407.34M USD — |
|
US Tech CTA Artificial Intellige
NQROBO
US
|
1953.16 USD — |
-0.99
|
— — | 1944.42 USD — | 1969.34 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
4006.39 USD — |
-1.69
|
— — | 3993.97 USD — | 4049.67 USD — | — - | — — |
|
US Tech CRD Global Sustainabilit
NQCRD
US
|
1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
|
The Capital Strength Index
NQCAPST
US
|
3547.32 USD — |
+0.34
|
— — | 3536.26 USD — | 3561.54 USD — | — - | — — |
|
US Tech US Broad Dividend Achiev
DAATR
US
|
8533.74 USD — |
-0.06
|
— — | 8519.61 USD — | 8573.22 USD — | — - | — — |
|
US Tech OMX CRD Global Sustainab
QCRD
US
|
1595.1 USD — |
0
|
— — | — — | — — | — - | — — |
|
Interbrand Best Global Brands N
BRAND100N
US
|
987.01 USD — |
0
|
— — | 987.01 USD — | 987.01 USD — | — - | — — |
|
US Tech US Smart Pharmaceuticals
NQSSPH
US
|
2029.79 USD — |
-0.27
|
— — | 2015.45 USD — | 2037.71 USD — | — - | — — |
|
Better Investing 100
BIXX
US
|
245.36 USD — |
0
|
— — | — — | — — | — - | — — |
|
US Tech US Price Setters Index
NQPRCE
US
|
3037.19 USD — |
+0.22
|
— — | 3031.27 USD — | 3046.36 USD — | — - | — — |
|
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
|
The Capital Strength Net Total
NQCAPSTN
US
|
4238.73 USD — |
+0.34
|
— — | 4225.52 USD — | 4255.73 USD — | — - | — — |
|
US Tech US Low Volatility Divide
LVDA
US
|
1333.81 USD — |
+0.59
|
— — | 1327.86 USD — | 1338.95 USD — | — - | — — |
|
NYSE Arca Pharmaceutical Index
DRG
US
|
1224.89 USD — |
-0.12
|
— — | — — | — — | — - | — — |
|
NYSE ARCA MAJOR MARKET INDEX
XMI
US
|
3944.79 USD — |
0
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}